Evidence map›Paper›PMID 38432392›Full record

ArticleJournal of advanced research2025

5-HT

Zhenfang Gao, Yang Gao, Yuxiang Li, Jie Zhou, Ge Li, Shun Xie, Ruiyan Jia, Lanying Wang, Ziying Jiang, Meng Liang and 13 more

Open access · goldAbstract read
In one paragraph

Article in Journal of advanced research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 1 country.

Zhenfang GaoBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Yang GaoBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Yuxiang LiBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Jie ZhouBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Ge LiBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Shun XieBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Ruiyan JiaBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Lanying WangBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Ziying JiangBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Meng LiangBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Chunxiao DuBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Yaqiong ChenBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Yinji LiuBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Lin DuBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Cong WangBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Shuaijie DouBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Zhonglin LvBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Lubin WangBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Renxi WangBeijing Institute of Brain Disorders, Capital Medical University, Beijing 100069, China.
Beifen ShenBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Zhiding WangBeijing Institute of Basic Medical Sciences, Beijing 100850, China. Electronic address: wzdfjfn@126.com.
Yunfeng LiBeijing Institute of Basic Medical Sciences, Beijing 100850, China. Electronic address: lyf619@aliyun.com.
Gencheng HanBeijing Institute of Basic Medical Sciences, Beijing 100850, China. Electronic address: genchenghan@163.com.
Beijing Institute of Education · CNCapital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionExcessive immune activation induces tissue damage during infection. Compared to external strategies to reconstruct immune homeostasis, host balancing ways remain largely unclear.

objectivesHere we found a neuroimmune way that prevents infection-induced tissue damage.

methodsBy FACS and histopathology analysis of brain Streptococcus pneumonia meningitis infection model and behavioral testing. Western blot, co-immunoprecipitation, and ubiquitination analyze the Fluoxetine initiate 5-HT7R-STUB1-CCR5 K48-linked ubiquitination degradation.

resultsFluoxetine, a selective serotonin reuptake inhibitor, or the agonist of serotonin receptor 5-HT

conclusionOur results reveal a neuroimmune pathway that balances anti-infection immunity via happiness neurotransmitter receptor and suggest the 5-HT

Indexed as

MeningitisNeuroimmunomodulationReceptors, CCR5Receptors, SerotoninAnimalsDisease Models, AnimalFluoxetineMaleMiceMice, Inbred C57BLSignal TransductionUbiquitinationUbiquitin-Protein LigasesCCR5 protein, mouseFluoxetineReceptors, CCR5Receptors, Serotoninserotonin 7 receptorUbiquitin-Protein Ligases5-HT(7)RCCR5MeningitisNeuroimmuneSTUB1Ubiquitination

Identifiers

PMID38432392
PMCPMC11785565
OpenAlexW4392385386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.